Issue link: https://beckershealthcare.uberflip.com/i/1393415
27 CFO / FINANCE What 5 health insurance CEOs were paid in 2020 By Lauren Jensik T he Wall Street Journal released its annual CEO pay and performance ranking June 1. The publication based its list on compensation figures reported by S&P 500 companies for CEOs who served in their roles for all of 2020. Here's what five payer CEOs made last year: 1. Centene CEO Michael Neidorff: $24,956,777 (down 5.6 percent from 2019) 2. CVS Health (Aetna) CEO Larry Merlo: $23,043,822 (down 37 percent from 2019) 3. Cigna CEO David Cordani: $19,929,493 (up 3.2 per- cent from 2019) 4. Anthem CEO Gail Boudreaux: $17,109,952 (up 11 per- cent from 2019) 5. Humana CEO Bruce Broussard: $16,489,639 (down 1.4 percent from 2019) n UnitedHealth's workforce in 6 numbers By Morgan Haefner U nitedHealth Group is one of the largest health- care companies in the U.S. and is continuing to grow its clinical and administrative teams. Six numbers that show the size and reach of United- Health's workforce, outlined in the company's 2021 sus- tainability report: 1. Employees: 330,000 2. Clinical professionals: 125,000 3. Customer-facing employees: 40,000 4. Technology professionals: 30,000 5. Countries with employees: 16 6. Individuals served: 142 million n Oncology OmniSeq INSIGHT SM Powering better decisions for your patients. Labcorp Oncology is expanding its repertoire of cutting-edge diagnostic tools in precision medicine. OmniSeq INSIGHT is our newest advancement in genomic and immune profiling for all solid tumors. Test results are packaged in a comprehensive, easy-to-read report summarizing: *within 200 miles of the patient's home OmniSeq INSIGHT SM is a service mark of OmniSeq, Inc. ©2021 Laboratory Corporation of America® Holdings All rights reserved. onc-2096-0621 FDA-APPROVED THERAPIES IMMUNOTHERAPIES + + ELIGIBLE CLINICAL TRIALS* onc_2096_0621_8.375x5.25_bleed_x1a.pdf 1 6/28/21 5:24 PM